PTPN2 and neoplasm: Yang et al. managed to specifically knockdown the PD-L1 and PTPN2 genes in tumour cells, attenuating inhibition of the JAK/STAT pathway, which in turn further amplified CD8 + T cell susceptibility to tumours [47].